OPKO Health (OPK) News Today $1.42 0.00 (0.00%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.42 0.00 (0.00%) As of 04/17/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Altshuler Shaham Ltd Purchases Shares of 1,411,019 OPKO Health, Inc. (NASDAQ:OPK)Altshuler Shaham Ltd acquired a new stake in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,411,019 shares of the biotechnologyApril 19 at 6:30 AM | marketbeat.comInvestors Buy Large Volume of OPKO Health Call Options (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Investors acquired 5,038 call options on the stock. This represents an increase of approximately 101% compared to the average volume of 2,501 call options.April 17 at 2:40 PM | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) boasts of bullish insider sentiment with 52% ownership and they have been buying latelyApril 16, 2025 | finance.yahoo.comNorges Bank Buys New Stake in OPKO Health, Inc. (NASDAQ:OPK)Norges Bank bought a new stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,127,468 shares of the biotechnology company's stock, valued at approximately $1,657,000. NorgesApril 14, 2025 | marketbeat.comQ3 Earnings Forecast for OPKO Health Issued By HC WainwrightOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for OPKO Health in a research note issued to investors on Monday, April 7th. HC Wainwright analyst Y. Chen now anticipates that the biotechnology company will poApril 12, 2025 | marketbeat.comNextPlat Corp.: NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development ProgramApril 12, 2025 | finanznachrichten.deQ3 Earnings Estimate for OPKO Health Issued By HC WainwrightApril 12, 2025 | americanbankingnews.comNextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development ProgramApril 11, 2025 | tmcnet.comOPKO Health, Inc. (NASDAQ:OPK) CEO Purchases $170,000.00 in StockApril 11, 2025 | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Acquires $185,000.00 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 125,000 shares of the stock in a transaction dated Tuesday, April 8th. The shares were bought at an average price of $1.48 per share, with a total value of $185,000.00. Following the completion of the transaction, the chief executive officer now directly owns 213,876,448 shares of the company's stock, valued at $316,537,143.04. The trade was a 0.06 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.April 10, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for OPKO Health (NASDAQ:OPK)HC Wainwright restated a "buy" rating and issued a $3.00 price objective on shares of OPKO Health in a research note on Monday.April 9, 2025 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Buys 125,000 SharesApril 9, 2025 | insidertrades.com5OPK : OPKO Health Stock: A Deep Dive Into Analyst Perspectives...April 8, 2025 | benzinga.comOpko Health board authorizes $100M increase to existing share repurchase programApril 5, 2025 | markets.businessinsider.comOPKO Health (NASDAQ:OPK) Sees Strong Trading Volume Following Insider Buying ActivityOPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume After Insider Buying ActivityApril 4, 2025 | marketbeat.comOPKO Health Announces $100 Million Increase to its Existing Share Repurchase ProgramApril 4, 2025 | globenewswire.comOPKO Health, Inc. (NASDAQ:OPK) Short Interest Up 24.1% in MarchOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 111,000,000 shares, an increase of 24.1% from the February 28th total of 89,470,000 shares. Based on an average daily trading volume, of 4,640,000 shares, the short-interest ratio is presently 23.9 days. Currently, 36.6% of the company's stock are short sold.April 3, 2025 | marketbeat.comPhillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 100,000 shares of the business's stock in a transaction dated Tuesday, April 1st. The stock was bought at an average price of $1.65 per share, for a total transaction of $165,000.00. Following the purchase, the chief executive officer now owns 213,751,448 shares in the company, valued at approximately $352,689,889.20. This represents a 0.05 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.April 3, 2025 | marketbeat.comPiper Sandler Remains a Buy on Opko Health (OPK)April 3, 2025 | markets.businessinsider.comNorth Jersey biotech company to lay off 81, continuing industry trendApril 1, 2025 | msn.comN.J. laboratory lays off 81 employees after Labcorp takeoverApril 1, 2025 | msn.comPhillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 150,000 shares of OPKO Health stock in a transaction dated Friday, March 28th. The stock was acquired at an average price of $1.70 per share, with a total value of $255,000.00. Following the acquisition, the chief executive officer now directly owns 213,651,448 shares of the company's stock, valued at approximately $363,207,461.60. This represents a 0.07 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.March 29, 2025 | marketbeat.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Purchases 150,000 Shares of StockMarch 29, 2025 | insidertrades.comCharles Schwab Investment Management Inc. Cuts Position in OPKO Health, Inc. (NASDAQ:OPK)Charles Schwab Investment Management Inc. lowered its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 17.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,497,406 shares of the biotechnology company's sMarch 26, 2025 | marketbeat.comZacks Research Weighs in on OPKO Health FY2027 EarningsOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Zacks Research issued their FY2027 earnings estimates for shares of OPKO Health in a research report issued to clients and investors on Thursday, March 20th. Zacks Research analyst R. Department anticipates that the biotMarch 24, 2025 | marketbeat.comChairman & CEO of OPKO Health Phillip Frost Buys More StockMarch 20, 2025 | finance.yahoo.comOPKO Health (NASDAQ:OPK) Given Buy Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $3.00 target price on shares of OPKO Health in a report on Wednesday.March 20, 2025 | marketbeat.comPhillip Md Et Al Frost Purchases 200,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 200,000 shares of the company's stock in a transaction dated Monday, March 17th. The shares were acquired at an average cost of $1.74 per share, with a total value of $348,000.00. Following the acquisition, the chief executive officer now directly owns 213,501,448 shares of the company's stock, valued at approximately $371,492,519.52. This represents a 0.09 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 18, 2025 | marketbeat.comOpko and Entera focus on oral care for obesity and metabolic disordersMarch 18, 2025 | finance.yahoo.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Acquires 200,000 Shares of StockMarch 18, 2025 | insidertrades.comOPKO and Entera partner to develop obesity pillMarch 17, 2025 | msn.comOpko Health CEO buys $348K in common stockMarch 17, 2025 | markets.businessinsider.comQ2 Earnings Forecast for OPKO Health Issued By HC WainwrightOPKO Health, Inc. (NASDAQ:OPK - Free Report) - HC Wainwright raised their Q2 2025 earnings per share (EPS) estimates for OPKO Health in a report issued on Wednesday, March 12th. HC Wainwright analyst Y. Chen now expects that the biotechnology company will post earnings of ($0.07) per share for thMarch 17, 2025 | marketbeat.comIs OPKO Health, Inc. (OPK) The Best Stock Under $3 to Buy Now?March 14, 2025 | insidermonkey.comEssential Planning LLC. Takes Position in OPKO Health, Inc. (NASDAQ:OPK)Essential Planning LLC. acquired a new stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 331,175 shares of the biotechnology company's stock, valued at approximately $506,000. AMarch 14, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $3.00 price objective on shares of OPKO Health in a research note on Wednesday.March 13, 2025 | marketbeat.comBarrington Research Reaffirms Outperform Rating for OPKO Health (NASDAQ:OPK)Barrington Research reaffirmed an "outperform" rating and set a $2.25 price target on shares of OPKO Health in a research report on Wednesday.March 13, 2025 | marketbeat.comOpko Health to sell more assets to Labcorp for $225 millionMarch 12, 2025 | bizjournals.comOPKO Health (NASDAQ:OPK) Shares Gap Up - Here's What HappenedOPKO Health (NASDAQ:OPK) Shares Gap Up - Here's What HappenedMarch 12, 2025 | marketbeat.comLabcorp, Opko Health acquire certain assets of BioReference HealthMarch 11, 2025 | markets.businessinsider.comLabcorp to Buy Some OPKO BioReference Assets for Up to $225 MillionMarch 11, 2025 | marketwatch.comLabcorp to acquire certain assets of Opko Health’s BioReference HealthMarch 11, 2025 | markets.businessinsider.comLabcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services BusinessesMarch 11, 2025 | prnewswire.comOPKO Health (NASDAQ:OPK) Shares Up 3.1% - What's Next?OPKO Health (NASDAQ:OPK) Trading Up 3.1% - Should You Buy?March 7, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Hits New 1-Year High - Here's WhyOPKO Health (NASDAQ:OPK) Reaches New 52-Week High - Here's WhyMarch 6, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Up 3.1% - Here's What HappenedOPKO Health (NASDAQ:OPK) Trading 3.1% Higher - Should You Buy?March 5, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Rating Increased to Hold at StockNews.comStockNews.com upgraded OPKO Health from a "sell" rating to a "hold" rating in a research report on Monday.March 4, 2025 | marketbeat.comBarrington Research Reaffirms "Outperform" Rating for OPKO Health (NASDAQ:OPK)Barrington Research restated an "outperform" rating and issued a $2.25 target price on shares of OPKO Health in a research note on Friday.March 1, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Reaches New 52-Week High on Strong EarningsOPKO Health (NASDAQ:OPK) Reaches New 1-Year High After Better-Than-Expected EarningsMarch 1, 2025 | marketbeat.comOPKO Health Full Year 2024 Earnings: Beats ExpectationsMarch 1, 2025 | finance.yahoo.com Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address OPK Media Mentions By Week OPK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPK News Sentiment▼0.840.58▲Average Medical News Sentiment OPK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPK Articles This Week▼54▲OPK Articles Average Week Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FOLD News Today LGND News Today BCRX News Today DVAX News Today MNKD News Today CLDX News Today INVA News Today NVAX News Today GERN News Today MYGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPK) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPK Stock Free OPK Stock Alerts